10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001628280-20-015999`
Period End Date	20200930
Filing Date	20201109
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	ameh-20200930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 110 Income Statement 84 Cash Flow Statement 130 Stockholders Equity 52

Balance Sheet 110 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.19M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$166.08M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.89M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$230.30M	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	-	USD	Point-in-time
Restricted cash	`RestrictedCashCurrent`	$75.00K	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$116.54M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$118.31M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$18.26M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$11.00M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$48.14M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$41.52M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$3.99M	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$16.89M	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$12.12M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$10.31M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	35.91M	shares	Point-in-time
Loan receivable	`NotesAndLoansReceivableNetCurrent`	$6.42M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	36.78M	shares	Point-in-time
Loan receivable	`NotesAndLoansReceivableNetCurrent`	$6.42M	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	17.48M	shares	Point-in-time
Loan receivable related parties	`NotesReceivableRelatedPartiesCurrent`	$16.50M	USD	Point-in-time
Loan receivable related parties	`NotesReceivableRelatedPartiesCurrent`	-	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	17.46M	shares	Point-in-time
Assets	`Assets`	$814.27M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$366.70M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$329.07M	USD	Point-in-time
Assets	`Assets`	$728.71M	USD	Point-in-time
Liabilities	`Liabilities`	$386.12M	USD	Point-in-time
Liabilities	`Liabilities`	$367.65M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$746.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$746.00K	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$12.13M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$10.93M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$103.01M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$90.78M	USD	Point-in-time
Goodwill	`Goodwill`	$238.50M	USD	Point-in-time
Goodwill	`Goodwill`	$239.05M	USD	Point-in-time
Investment in other entities equity method	`EquityMethodInvestments`	$27.22M	USD	Point-in-time
Investment in other entities equity method	`EquityMethodInvestments`	$28.43M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$37.08M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$19.30M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$14.25M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$22.47M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.68M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$399.64M	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$447.57M	USD	Point-in-time
Total assets	`Assets`	$814.27M	USD	Point-in-time
Total assets	`Assets`	$728.71M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$27.28M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$40.47M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$2.03M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$3.99M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$33.64M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$57.45M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$58.73M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$53.82M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$4.53M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$16.17M	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$485.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$271.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$102.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$102.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.29M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.99M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$9.50M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$9.50M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$105.42M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$131.46M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$11.66M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$18.27M	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$416.00K	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$337.00K	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$11.37M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$16.62M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$226.05M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$232.17M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$262.23M	USD	Point-in-time
Total noncurrent liabilities	`LiabilitiesNoncurrent`	$254.66M	USD	Point-in-time
Total liabilities	`Liabilities`	$386.12M	USD	Point-in-time
Total liabilities	`Liabilities`	$367.65M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$168.72M	USD	Point-in-time
Noncontrolling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$198.73M	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 36,775,817 and 35,908,057 shares outstanding, excluding 17,475,707 and 17,458,810 treasury shares, as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$36.00K	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 36,775,817 and 35,908,057 shares outstanding, excluding 17,475,707 and 17,458,810 treasury shares, as of September 30, 2020 and December 31, 2019, respectively	`CommonStockValue`	$37.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$159.61M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$168.65M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$59.71M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$31.91M	USD	Point-in-time
Total stockholders' equity, parent	`StockholdersEquity`	$228.40M	USD	Point-in-time
Total stockholders' equity, parent	`StockholdersEquity`	$191.55M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$1.01M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$786.00K	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.17M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$229.42M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$207.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$197.96M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders equity	`LiabilitiesAndStockholdersEquity`	$814.27M	USD	Point-in-time
Total liabilities, mezzanine equity and stockholders equity	`LiabilitiesAndStockholdersEquity`	$728.71M	USD	Point-in-time

Income Statement 84 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$180.12M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$510.40M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$381.87M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$156.06M	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	$402.11M	USD	3 Qtrs
Cost of services	`CostOfGoodsAndServicesSold`	$131.13M	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	$121.82M	USD	1 Quarter
Cost of services	`CostOfGoodsAndServicesSold`	$315.93M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$30.03M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$7.95M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$39.66M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$16.27M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts`	$13.79M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts`	$4.67M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts`	$4.92M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts`	$14.00M	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$-1.36M	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$1.99M	USD	1 Quarter
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	3 Qtrs
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$1.99M	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$360.38M	USD	3 Qtrs
Total expenses	`CostsAndExpenses`	$145.99M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$142.77M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$455.77M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$21.49M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$10.07M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$54.63M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$37.36M	USD	1 Quarter
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.05M	USD	1 Quarter
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$3.29M	USD	3 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.16M	USD	3 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$403.00K	USD	1 Quarter
Equity Method Investment, Realized Gain (Loss) on Disposal	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	3 Qtrs
Equity Method Investment, Realized Gain (Loss) on Disposal	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$99.65M	USD	3 Qtrs
Equity Method Investment, Realized Gain (Loss) on Disposal	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	1 Quarter
Equity Method Investment, Realized Gain (Loss) on Disposal	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$2.47M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.35M	USD	3 Qtrs
Interest expense	`InterestExpense`	$828.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$8.01M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.54M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$752.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$1.30M	USD	3 Qtrs
Interest income	`InvestmentIncomeInterest`	$509.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$2.83M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$2.62M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$130.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$1.51M	USD	3 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$98.99M	USD	3 Qtrs
Total other (expense) income, net	`NonoperatingIncomeExpense`	$4.36M	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-1.18M	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$3.95M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$36.17M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$153.62M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$25.44M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$14.42M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$3.68M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$10.75M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$44.20M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$6.48M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$25.42M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$109.41M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$18.95M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$10.74M	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$8.71M	USD	1 Quarter
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$11.56M	USD	3 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$81.60M	USD	3 Qtrs
Net income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.04M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$7.39M	USD	3 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$27.81M	USD	3 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$16.71M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$3.70M	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.21	USD	3 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.46	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.11	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.77	USD	3 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.75	USD	3 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.10	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.45	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.20	USD	3 Qtrs

Cash Flow Statement 130 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$25.42M	USD	1 Quarter
Net income	`ProfitLoss`	$109.41M	USD	3 Qtrs
Net income	`ProfitLoss`	$18.95M	USD	3 Qtrs
Net income	`ProfitLoss`	$10.74M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$13.79M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.00M	USD	3 Qtrs
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$1.99M	USD	1 Quarter
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	3 Qtrs
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	1 Quarter
Impairment of intangibles	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$1.99M	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.00M	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$-1.36M	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	-	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$2.56M	USD	3 Qtrs
Share-based compensation	`ShareBasedCompensation`	$1.01M	USD	3 Qtrs
Unrealized loss (gain) from investment in equity securities	`UnrealizedGainLossOnInvestments`	$6.00K	USD	3 Qtrs
Unrealized loss (gain) from investment in equity securities	`UnrealizedGainLossOnInvestments`	$-23.00K	USD	3 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.05M	USD	1 Quarter
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$3.29M	USD	3 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.16M	USD	3 Qtrs
Income from equity method investments	`IncomeLossFromEquityMethodInvestments`	$403.00K	USD	1 Quarter
Gain on sale of equity method investments	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	3 Qtrs
Gain on sale of equity method investments	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$99.65M	USD	3 Qtrs
Gain on sale of equity method investments	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	1 Quarter
Gain on sale of equity method investments	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	1 Quarter
Gain on loan assumption	`GainLossOnAssumptionOfLoan`	$2.25M	USD	3 Qtrs
Gain on loan assumption	`GainLossOnAssumptionOfLoan`	-	USD	3 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-6.14M	USD	3 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-186.00K	USD	3 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$6.95M	USD	3 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$-1.90M	USD	3 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$-5.86M	USD	3 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$-6.62M	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-12.90M	USD	3 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$13.72M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$2.91M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$1.80M	USD	3 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$1.88M	USD	3 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$2.60M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$5.09M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$525.00K	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$12.64M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$4.87M	USD	3 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$1.96M	USD	3 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$196.00K	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-1.57M	USD	3 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-6.23M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$11.64M	USD	3 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-10.23M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	$-2.11M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	$-1.79M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$48.76M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$10.09M	USD	3 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$49.40M	USD	3 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	-	USD	3 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$16.50M	USD	3 Qtrs
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	3 Qtrs
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$7.42M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$20.00K	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.79M	USD	3 Qtrs
Purchases of investments equity method	`PaymentsToAcquireEquityMethodInvestments`	$500.00K	USD	3 Qtrs
Purchases of investments equity method	`PaymentsToAcquireEquityMethodInvestments`	$2.95M	USD	3 Qtrs
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	3 Qtrs
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	$52.74M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$553.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$807.00K	USD	3 Qtrs
Dividend received	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$240.00K	USD	3 Qtrs
Dividend received	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-60.36M	USD	3 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$66.40M	USD	3 Qtrs
Repayment of bank loan and lines of credit	`RepaymentsOfBankLoanAndLinesOfCredit`	-	USD	3 Qtrs
Repayment of bank loan and lines of credit	`RepaymentsOfBankLoanAndLinesOfCredit`	$52.64M	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$50.13M	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$60.67M	USD	3 Qtrs
Repayment of term loan	`RepaymentsOfLongTermDebt`	$7.12M	USD	3 Qtrs
Repayment of term loan	`RepaymentsOfLongTermDebt`	-	USD	3 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$76.00K	USD	3 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$26.00K	USD	1 Quarter
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$26.00K	USD	1 Quarter
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$78.00K	USD	3 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$6.55M	USD	3 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$2.40M	USD	3 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$40.00K	USD	3 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$1.56M	USD	3 Qtrs
Borrowings on line of credit	`ProceedsFromLongTermLinesOfCredit`	$289.60M	USD	3 Qtrs
Borrowings on line of credit	`ProceedsFromLongTermLinesOfCredit`	-	USD	3 Qtrs
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	$755.00K	USD	3 Qtrs
Proceeds from common stock offering	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Cost of debt and equity issuance costs	`PaymentOfFinancingAndStockIssuanceCosts`	$5.62M	USD	3 Qtrs
Cost of debt and equity issuance costs	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$173.71M	USD	3 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-52.34M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$62.82M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$123.43M	USD	3 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.06M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$166.83M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.06M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$166.83M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$37.90M	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$17.90M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$1.00M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$6.96M	USD	3 Qtrs
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilitiesAdjustedToGoodwill`	-	USD	3 Qtrs
Deferred tax liability adjustment to goodwill	`DeferredTaxLiabilitiesAdjustedToGoodwill`	$11.54M	USD	3 Qtrs
Deferred tax liability adjustment related to warrant exercises	`DeferredTaxLiabilitiesWarrantsExercised`	$473.00K	USD	3 Qtrs
Deferred tax liability adjustment related to warrant exercises	`DeferredTaxLiabilitiesWarrantsExercised`	-	USD	3 Qtrs
APC stock issued in exchange for AMG	`StockIssued1`	-	USD	3 Qtrs
APC stock issued in exchange for AMG	`StockIssued1`	$414.00K	USD	3 Qtrs
Preferred shares received from sale of equity method investment	`NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1`	-	USD	3 Qtrs
Preferred shares received from sale of equity method investment	`NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1`	$36.18M	USD	3 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$103.19M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$166.08M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$106.89M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$230.30M	USD	Point-in-time
Restricted cash non-current	`RestrictedCashEquivalentsNoncurrent`	$746.00K	USD	Point-in-time
Restricted cash non-current	`RestrictedCashEquivalentsNoncurrent`	$746.00K	USD	Point-in-time
Restricted cash non-current	`RestrictedCashEquivalentsNoncurrent`	$746.00K	USD	Point-in-time
Restricted cash non-current	`RestrictedCashEquivalentsNoncurrent`	$745.00K	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$231.06M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$166.83M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$107.64M	USD	Point-in-time

Stockholders Equity 52 line items

Line Item	Tag	Value	Unit	Period
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.17M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$229.42M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$207.85M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$197.96M	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$4.46M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$4.15M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$16.90M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$3.77M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$550.00K	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$7.33M	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	-	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$301.00K	USD	1 Quarter
Purchase of noncontrolling interest	`MinorityInterestDecreaseFromRedemptions`	-	USD	1 Quarter
Purchase of noncontrolling interest	`MinorityInterestDecreaseFromRedemptions`	-	USD	1 Quarter
Purchase of noncontrolling interest	`MinorityInterestDecreaseFromRedemptions`	-	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for exercise of cashless warrants (in shares)	`StockIssuedDuringPeriodSharesCashlessWarrantsExercised`	66,517.00	shares	3 Qtrs
Shares issued for cashless exercise of warrants	`StockIssuedDuringPeriodValueCashlessWarrantsExercised`	-	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$2.28M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.50M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$140.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$4.02M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$758.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$722.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$648.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.06M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$852.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$128.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$143.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$128.00K	USD	1 Quarter
Stock subscriptions	`StockIssuedDuringPeriodValueNewIssues`	-	USD	1 Quarter
Stock issued in connection with a business combination	`StockIssuedDuringPeriodValueAcquisitions`	-	USD	1 Quarter
Cost related to issuance of preferred shares	`AllocatedShareBasedCompensationExpenseNetOfTax`	-	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardCancelled`	$236.00K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$347.00K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$942.00K	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Dividends	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$186.09M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.17M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$182.38M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$229.42M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$181.54M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$207.85M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$197.96M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.